Antiplasmodial effects of the aqueous extract of phyllantus amarus schumach and thonn against plasmodium Berghei in Swiss albino mice by Dapper, D.V et al.
19
Nigerian Journal of Physiological Sciences 22 (1-2): 19-25©Physiological Society of Nigeria, 2007.
Available online/abstracted at http://www.biolineinternational.org.br/njps; www.ajol.info/journals.njps;  www.cas.org
ANTIPLASMODIAL EFFECTS OF THE AQUEOUS EXTRACT OF PHYLLANTUS AMARUS
SCHUMACH AND THONN AGAINST PLASMODIUM BERGHEI IN SWISS ALBINO MICE
D. V. DAPPER, B. N. AZIAGBA and O. O. EBONG1
Department of Human Physiology and Malaria Research Unit, Department of Pharmacology1
Faculty of Basic Medical Sciences, College of Health Sciences,
University of Port Harcourt, PMB 5323, Port Harcourt, Nigeria.
e-mail: dapperdv2001@yahoo.com,
Tel: +234805600570
Summary: Phyllantus amarus Schumach and Thonn is a medicinal plant used commonly for the 
treatment of malaria-related symptoms by the general public in southeastern Nigeria. The present study 
determines the possible antiplasmodial effects of the aqueous extract of the leaves and stem of the plant 
against Plasmodium berghei infection using Swiss albino mice as models.  The blood schizonticidal 
activity of the aqueous extract in early infection and in established Plasmodium berghei infection was 
assessed and compared to the activities of chloroquine and sulfadoxine/pyrimethamine. The repository 
activity of the extract was also assessed and compared to the activity of pyrimethamine. The LD50 of 
the aqueous extract of the leaves and stem of the plant was also determined using albino Wistar rats. 
The results show that the LD50 of the aqueous extract of Phyllantus amarus Schumach and Thonn was 
650 mg/kg. In early infection, the extract at doses of 108.33 mg/kg, 165 mg/kg and 325 mg/kg was 
found to cause a significant dose-dependent suppression of P berghei parasites (P<0.05) 
sulfadoxine/pyrimethamine caused a similar significant suppression of P berghei parasites (P<0.05) 
while chloroquine at a dose of 5 mg/kg did not cause a significant effect on P berghei parasites. 
Similarly, the extract was found at all doses to cause a statistically significant (P<0.05) suppression of 
P berghei parasites via a repository action. This effect was comparable to the effects of pyrimethamine 
a standard repository agent. In established infection, the extract at all doses administered, was found to 
significantly suppress P berghei parasites at 24 and 72-hour periods (P<0.05). Comparatively, 
sulfadoxine/pyrimethamine caused a similar statistical (P<0.05) suppression of the parasites of P 
berghei. However, the effects of sulfadoxine/pyrimethamine were more sustained over the 72-hour 
period. The present study therefore validates the local use of the extracts of Phyllantus amarus 
Schumach and Thonn as an antimalarial agent. Further studies are however recommended to identify 
and possibly characterize the potential antiplasmodial agents in the aqueous extract of the plant.
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Introduction
Malaria, a disease caused by Plasmodium
infection, is still the most important human 
parasitic disease in the world: 40% of the world 
population is at risk with an annual fatality of 
1.5-2.7 million; highest amongst under-five year 
olds (Murnigsih et al 2005). Research into the 
identification and production of more effective, 
cheaper and potentially less toxic remedies for 
the treatment of malaria would therefore 
continue to be relevant (Didia et al, 2002).  
Phyllantus amarus Schumach and Thonn is 
a plant of the Euphorbiaceae family. It is a wild 
herb of the Amazonian forest, though widely 
distributed in the tropics and sub-tropics 
[Bagchi et al 1992; Ross 1999]. Across Nigeria, 
it is known by several local names and is 
regarded as a plant of general medicinal 
application. Traditional local uses in Nigeria 
include as a treatment of diarrhea and gastro-
intestinal disorders (Odetola and Akojenu, 
2000) and as a food additive for puerperal and 
lactating mothers. It is also used in southeastern 
Nigeria to treat malaria-related symptoms. The 
parts of the plant used include the dried leaves 
and the stem. 
The medicinal uses and effects of the 
extracts of Phyllantus amarus Schumach and 
Thonn have been well documented. Phyllantus 
amarus extracts has been found to have 
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hepatoprotective effects (Lee et al 2006), to 
exhibit hypoglycemic effects and thus useful for 
the treatment of diabetes mellitus (Raphael et al
2002), to have anti-microbial properties 
(Mazumder et al 2006), to interfere with the 
formation of renal stones and therefore a useful 
alternative for the treatment and prevention 
urolithiasis (Barros et al 2003). Possible 
antispasmodic effects of the extract on smooth 
muscles have been reported to contribute to its 
effects in urolithiasis (Kassuya et al 2003). In 
addition, analgesic, anti-inflammatory, anti-
allodynic and anti-oedematogenic effects have 
been attributed to extracts of Phyllantus amarus
(Kassuya et al 2005; Kassuya et al 2006). A 
hepatic anti-tumor effect has also been reported 
in lower animals (Rajeshkumar and Kuttan 
2000; Rajeshkumar et al 2002). However, 
reports on the anti-viral properties of extracts of 
Phyllantus amarus have been extensive but 
conflicting: A number of reports indicate an 
effectiveness in the eradication of hepatitis B 
virus in chronic carriers (Thyagarajan et al
1988; Thamlikitkul et al 1991; Doshi et al
1994), other reports suggests failure to respond 
(Milne et al 1994). Perhaps these conflicts could 
be resolved with a rigorous clinical trial. An in 
vivo and in vitro inhibitory effect on replication 
of the human immunodeficiency virus has also 
been documented (Notka et al 2004). 
Recent reports on studies of the 
antibacterial, anti-inflammatory and antimalarial 
activities of some Nigerian medicinal plants did 
not include Phyllantus amarus Schumach and 
Thonn (Chukwujekwu et al 2005) in spite of its 
widespread use for fever in the southeastern 
parts. Adedapo et al 2005 in their studies on the 
effect of Phyllantus amarus on the serum 
biochemistry of rats reported that the plant was 
toxic (Adedapo et al 2005) This study seeks to 
determine the possible antiplasmodial effects of 
the aqueous extract of P amarus against 
Plasmodium berghei using Swiss albino mice as 
models, in order to ascertain the true value of its 
use in the treatment of malaria.  
Materials and Methods
Identification of Plant Material
Fresh leaves and stem of P amarus were 
collected in June 2006 from local gardens at the 
University of Port Harcourt, Nigeria. Dr. G 
Obute, an academic staff of the Department of 
Plant Science and Biotechnology, Faculty of 
Science, University of Port Harcourt, Nigeria 
correctly identified the plant. Voucher 
specimens were deposited in the Malaria 
Research Unit, Department of Pharmacology, 
College of Health Sciences, University of Port 
Harcourt, Nigeria for future reference.
Drugs
Pyrimethamine tablet was obtained from 
Glaxo-Wellcome. The combination of 
sulfadoxine and pyrimethamine was obtained 
from Roche; each tablet contains 500mg 
sulfadoxine and 25mg pyrimethamine. Each 
tablet was ground into a fine powder before use. 
Parentheral chloroquine was obtained from May 
and Baker.
Preparation of aqueous extract
The leaves and stem were sorted to remove 
any contaminants, dead matter and sand 
particles and then air dried for 28 days. The 
dried leaves and stem were then ground into a 
fine powder with the aid of an electric dry mill 
(Moulinex). 100g of the ground powder was 
then thoroughly soaked in 600ml of distilled 
water for 48 hours at room temperature. The 
mixture was filtered into 250ml conical flask 
with Watman filter paper number one. The 
filtrate was dried at a temperature of 30°C for 
10 hours to produce a gel like extract, which 
weighed 11.335g. Appropriate concentrations of 
the extract were then subsequently made by 
serial dilution with distilled water for further 
experimentation.  
Acute Toxicity Test: Determination of LD50
The acute toxicity of P amarus extract was 
estimated using 42 albino Wistar rats weighing 
between 125 and 250g. The rats were divided 
into 7 groups consisting of 6 rats per group. 
Each group of rat was given a different dosage 
of the extract. The number of deaths in each 
group within 24 hours was recorded. The doses 
were given intraperitoneally using a 1ml 
disposable syringe. The LD50 was calculated 
using the formula of Kerber (Matselyukh et al 
2005). 
Animals and Inoculation
A total of 40 Swiss albino mice weighing 
between 15 and 25g were used for the study. 
The mice and the P berghei parasites were 
obtained from the Nigerian Institute of Medical 
Research, Lagos, Nigeria. The animals were fed 
with standard mouse cubes and tap water ad 
libitum and allowed 4-6 weeks to acclimatize to 
the new environment. 
Experimental Design
The experimental design involved three 
distinct experimental protocols:
Evaluation of Blood Schizonticidal activity in 
early infection: (The 4-day test)
This was done using a method similar to 
that described by Knight and Peters (1980). A 
total of 36 mice were used for studies on the 
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blood schizonticidal activity. Each mouse was 
subsequently given standard intra-peritoneal 
inoculums of 1.02 x 105 P berghei parasites 
(chloroquine-sensitive) with the aid of a 1ml 
disposable syringe. This was done to all the rat 
groups. The animals were then divided into six 
groups of 6 mice each: Groups 1 to 3 were 
given 325, 162.5 and 108.33mg/kg /day of the 
extract intraperitoneally respectively. Groups 4 
to 6 were treated as follows: group 4 was given 
5mg/kg /day of chloroquine intraperitoneally; 
group 5 was given 3mg/kg /day of 
sulfadoxine/pyrimethamine orally. Group 6 
were given 0.2ml of distilled water orally with 
the aid of a pipette. All the extracts, drugs and 
distilled water were given for 3 days. Group 6 
served as the control group. On the fourth day 
thick blood smears were made from blood 
samples obtained from the tails of the animals. 
The smears were stained with Giemsa stain and 
examined under the light microscope for the 
levels of parasitaemia. The average percentage 
suppression of parasitaemia was calculated in 
comparison to control. 
Evaluation of the Repository Activity
The repository activity was determined 
using the method described by Peters (1965). 
The mice were divided into 5 groups (A to E) 
consisting of 6 mice each. Groups A, B and C 
were given 325, 162.5 and 108.333mg/kg /day 
of the extract respectively. Group D were 
administered 1.2 mg/kg of pyrimethamine; 
while group E were administered 0.2ml of 
distilled water. The drugs, extracts and distilled 
water were given for three consecutive days. 
Group E served as the control group. On the 
fourth day all the animals were inoculated intra-
peritoneally with 1.02 x 105 P berghei parasites 
with the aid of a 1ml disposable syringe. 72 
hours after the inoculation thick blood smears 
were made and the level of parasitaemia 
determined as described above. 
Evaluation of the Blood Schizonticidal activity 
during established infection: (Rane Test)
This was determined using a method 
similar to that described by Ryley and Peters 
(1970). In this instance the animals were 
inoculated intra-peritoneally with 1.02 x 105 P 
berghei parasites with the aid of a 1ml 
disposable syringe. On the third day, the 
animals were subsequently divided into 6 
groups similar to and as described for the 
evaluation of blood schizonticidal activity 
above. Groups 1 to 3 were given 325, 162.5 and 
108.33mg/kg /day of the extract respectively. 
Group 4 was given 5mg/kg /day of chloroquine; 
group 5 was given 3mg/kg /day of 
sulfadoxine/pyrimethamine. Group 6 was given 
0.2ml of distilled water. In this experiment, 
group 6 mice served as the control group. The 
drugs were administered for five days. After 24 
and 72 hours of drug administration, blood 
smears were obtained as described earlier and 
the level of parasitaemia determined. The mean 
survival period was for each group within a 
28day period was determined and noted. 
Statistical Analysis
Results obtained are presented as 
meanstandard error of mean. Statistical 
analysis was done using the student’s t-test; a 
‘p’ value less than 0.05 were considered 
significant. 
Results
The results obtained for each experimental 
protocol are as presented in Tables 1 to 4.
LD50 values
The LD50 value of P amarus extracts in albino 
wistar rats was found to be 650-mg/kg. 
Blood schizonticidal activity of aqueous extract 
of P amarus in early infection: (The 4-day test)
Table 1 shows the blood schizonticidal 
activity of various doses of P amarus extract, 
chloroquine, sulfadoxine/pyrimethamine and 
distilled water. The average percentage 
parasitaemia and percentage suppression of P 
amarus at the highest dose administered was 
found to be 13.400.58 and 64.70 respectively; 
these values were found to be higher and lower 
respectively, than values obtained for 
sulfadoxine/pyrimethamine at a dose of 3mg/kg 
which were found to be 9.602.00 and 74.74 for 
average percentage parasitaemia and percentage 
suppression respectively. At all doses 
administered, P amarus extract and 
sulfadoxine/pyrimethamine at a dose 3mg/kg 
bw both caused a statistically significant 
suppression of P berghei activity in early 
infection (p<0.05). Chloroquine at a dose of 
5mg/kg caused an average percentage 
parasitaemia and average percentage 
suppression of 31.703.17 and 16.40 
respectively; these differences were however 
not significant (p>0.05). 
Antiplasmodial effects of Phyllantus amarus
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108.33 27.531.45 27.55 Yes
p<0.05








































Repository activity of aqueous extract of P 
amarus 
Table 2 shows the repository activity of P 
amarus compared to pyrimethamine. The 
highest dose of P amarus extract caused an 
average percentage parasitaemia and average 
percentage suppression of 6.930.88 and 80.62 
respectively. Pyrimethamine at a dose of 
1.20mg/kg caused an average percentage 
parasitaemia and average percentage 
suppression of 4.00.58 and 88.60 respectively. 
The effects of pyrimethamine and P amarus at 
all doses administered were found to be 
statistically significant (p<0.05). 
Blood schizonticidal activity of aqueous extract 
of P amarus in established infection: [Rane 
Test]
Tables 3 and 4 show the blood 
schizonticidal activity of the extract P amarus at 
24 and 72-hour periods respectively following 
established infection of P berghei: At 24 hours, 
the highest dose of P amarus extract 
administered caused an average percentage 
parasitaemia and average percentage 
suppression of 5.100.88 and 93.64 
respectively. At the dose of 3.0mg/kg the values 
for sulfadoxine/pyrimethamine were 3.602.0 
and 95.51 respectively; and values for 
chloroquine at the dose of 5.0mg/kg were found 
to be 40.501.44 and 49.50 respectively. These 
values were found to be statistically significant 
(p<0.05). However, at 72 hours, the highest 
dose of P amarus administered caused an 
average percentage parasitaemia and average 
percentage suppression of 18.870.88 and 79.93 
respectively suggesting a reduction in its 
effectiveness. Comparatively, the effects of 
sulfadoxine/pyrimethamine were sustained as 
the average percentage parasitaemia and 
average percentage suppression were found to 
be 2.700.50 and 97.13 respectively. These 
values were however also found to be 
statistically significant (p<0.05). At 72hours 
chloroquine at the dose of 5mg/kg bw actually 
induced a negative percentage average 
suppression. 
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Table 3: Blood schizonticidal activity of aqueous extract of P amarus during established infection






















108.33 13.870.66 82.72 Yes
p<0.05









Table 4: Blood schizonticidal activity of aqueous extract of P amarus during established infection






















108.33 28.401.52 69.79 Yes
p<0.05










This study suggests that the aqueous extract 
of P amarus possesses antiplasmodial actions 
against P berghei parasites in early infection 
and in established infections. The extract also 
exhibits repository actions against P berghei 
parasites and its effects are dose dependent. The 
highest dose of Phyllantus amarus Schumach 
and Thonn administered in the present study 
was half of the LD50. 
The results of the present study would 
suggests that the effects of the aqueous extract 
of P amarus are not sustained compared to the 
effects of the combination of pyrimethamine 
and sulfadoxine in established P berghei 
infection. The average percentage parasitaemia 
at 24-hours following the administration of the 
extract was found to be 5.100.88; this however 
increased to 18.870.88 at 72-hours. 
Comparatively the corresponding values for the 
combination of pyrimethamine and sulfadoxine 
at 24-hours was 3.602.0, the value however 
reduced to 2.700.5 at 72-hours. The data 
obtained therefore suggests that the 
antiplasmodial effects of the aqueous extracts of 
P amarus unlike that of 
sulfadoxine/pyrimethamine are not sustained. 
The actual agent(s) in the extract of P. amarus 
causing these antiplasmodial effects and the 
possible mechanisms of action need to be 
determined further. 
The results of the present study suggest that 
the aqueous extracts of Phyllantus amarus 
Schumach and Thonn has potential 
antiplasmodial and thus antimalarial properties. 
These results therefore validate its local use as 
an antimalarial agent in southeastern Nigeria.  
Antiplasmodial effects of Phyllantus amarus
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In conclusion, the present study reports that 
the aqueous extracts of Phyllantus amarus
Schumach and Thonn possess antiplasmodial 
activity against P berghei infection in Swiss 
albino mice. The study therefore fairly validates 
the local use of the extracts of Phyllantus 
amarus as an antimalarial agent in southeastern 
Nigeria. 
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